Gresham House Strategic Plc Price/Sales
What is the Price/Sales of Gresham House Strategic Plc?
The Price/Sales of Gresham House Strategic Plc is 2.62
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Finance sector on LSE compared to Gresham House Strategic Plc
What does Gresham House Strategic Plc do?
Gresham House Strategic plc specializes in PIPE, pre-IPO, growth and acquisition, recovery capital investments. The fund invests in financial services, media, information and communication technology, digital information and technology, healthcare, and life sciences. It prefers to invest in companies based in United Kingdom and Europe and can also co-invest outside Europe with local venture capital firms. The fund also seeks to make follow on investments. It invests in companies with market capitalizations of less than £250 million ($283.87 million) and seeks to acquire stakes between 5% and 25% for cash or share consideration. It seeks to invest between three to five years. The fund invests in smaller public companies as well as private companies. It invests in public companies that are listed on FTSE All-share and AIM All-Share Index; stocks trading greater than 50% below 3 year price high; EV or EBITDA less than 7 times, gearing more than 75%, ROCE greater than 10%, FCF Yield greater than 10%. The fund invests in private companies in P2P opportunities, equity and equity-related instruments, preferred equity, preferred quasi equity positions including convertible and non-convertible debt instruments, and mezzanine preferred instruments. It attracts portfolio in scenarios - excluding cash, portfolio trades on a weighted average EV or EBITDA greater than 5 times; generating in excess of 10% growth in 2017 based on broker forecasts. The fund targets 15% net IRR over the long-term.
Companies with price/sales similar to Gresham House Strategic Plc
- Sunny Optical Technology () has Price/Sales of 2.62
- Atari SA has Price/Sales of 2.62
- Vitasoy International has Price/Sales of 2.62
- TAG Oil has Price/Sales of 2.62
- Hao Tian Development has Price/Sales of 2.62
- Crocodile Garments has Price/Sales of 2.62
- Gresham House Strategic Plc has Price/Sales of 2.62
- Ansila NL has Price/Sales of 2.62
- Atlanta Braves Inc has Price/Sales of 2.62
- COSCIENS Biopharma has Price/Sales of 2.62
- Burberry Plc has Price/Sales of 2.62
- Allegion plc has Price/Sales of 2.62
- Kooth plc has Price/Sales of 2.62